June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Improving autophagy rescues pathologic angiogenesis and vision in a murine model of AMD
Author Affiliations & Notes
  • Emilie HECKEL
    Pharmacology, Montreal University, MONTREAL, Quebec, Canada
  • Sheetal Pundir
    Pharmacology, McGill University, MONTREAL, Quebec, Canada
  • jin sung-kim
    Pharmacology, McGill University, MONTREAL, Quebec, Canada
  • Jean-Sebastien Joyal
    Pharmacology, McGill University, MONTREAL, Quebec, Canada
    Pharmacology, CHU Sainte-Justine, Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships   Emilie HECKEL, None; Sheetal Pundir, None; jin sung-kim, None; Jean-Sebastien Joyal, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 813. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Emilie HECKEL, Sheetal Pundir, jin sung-kim, Jean-Sebastien Joyal; Improving autophagy rescues pathologic angiogenesis and vision in a murine model of AMD. Invest. Ophthalmol. Vis. Sci. 2017;58(8):813.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Drivers of pathological angiogenesis that contribute to vision loss in age related macular degeneration (AMD) are not well understood. Dysregulated glucose and lipid metabolism in photoreceptors create a fuel shortage that attract pathological neovessels in an attempt to reinstate energy homeostasis in AMD. Fuel deficient photoreceptors are capable of autophagy, the mechanism by which cells recycle intracellular nutrients to fuel mitochondria. We hypothesize that deregulated autophagy in a mice model of AMD exacerbates the energy failure of photoreceptors leading to pathological angiogenesis and blindness.

Methods : Subretinal vascular lesions of Vldlr-/- mice were characterized by confocal imaging of lectin-stained retinal flat mounts. Markers of autophagy and energy metabolism were assessed by qRT-PCR, Western blot and immunofluorescence. Retinal metabolite profiling was quantified by liquid chromatography and tandem mass spectrometry (LC/MS/MS). Electroretinograms (ERG) were recorded from Vldlr-/- and WT mice, treated or not with various autophagy enhancing drugs (P7 to P30). Scotopic recordings were performed under increasing light intensities. Photopic recordings were performed following 3 min light adaptation intervals.

Results : Very low-density lipoprotein receptor (VLDLR) is expressed in photoreceptors and facilitates the uptake of triglyceride-derived fatty acids. Vldlr-/- mice therefore present a relative fuel shortage in lipid. Paradoxically, markers of autophagy (Atg5, LC3-II, p62) and lipid metabolism (PPARα) were suppressed in Vldlr-/- mice compared to control (P<0.0006, n=7-12). Moreover, key Krebs cycle metabolite α-ketoglutarate (KG) was suppressed (P<0.007, n=11-15). We confirmed previous findings that low α-KG levels promote hypoxia-induced factor-1α (Hif1α) stabilization and vascular endothelial growth factor (Vegfa) secretion by starved Vldlr-/- photoreceptors, attracting neovessels to reinstate energy homeostasis. Pharmacological agonist that improve autophagy significantly reduced neovascular lesions in Vldlr-/- mice (57%; p<0.05) and improved their vision by ERG (32% higher a-wave and 28% reduction in a-wave latency; p<0.05).

Conclusions : Dysregulated autophagy may therefore contribute to the onset of AMD-like lesions by decreasing fuel supply to mitochondria. Means of regulating autophagy may offer a novel therapeutic strategy to alleviate neovascular AMD and improve vision.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×